Identifying Extended-Release Naltrexone Treatment for Opioid Use Disorder in US Medicaid Data.

Saved in:
Bibliographic Details
Title: Identifying Extended-Release Naltrexone Treatment for Opioid Use Disorder in US Medicaid Data.
Authors: Ross RK; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, USA., Butler AM; Division of Infectious Diseases, John T. Milliken Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA., Seamans MJ; Department of Epidemiology, Fielding School of Public Health, University of California, Los Angeles, California, USA., Williams AR; Department of Psychiatry, Columbia University, New York, New York, USA.; New York State Psychiatric Institute, New York, New York, USA., Samples H; Center for Pharmacoepidemiology and Treatment Science, Rutgers Institute of Health, Health Care Policy and Aging Research, New Brunswick, New Jersey, USA., Rudolph KE; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, USA.
Source: Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2026 Jan; Vol. 35 (1), pp. e70304.
Publication Type: Journal Article
Journal Info: Publisher: Wiley Country of Publication: England NLM ID: 9208369 Publication Model: Print Cited Medium: Internet ISSN: 1099-1557 (Electronic) Linking ISSN: 10538569 NLM ISO Abbreviation: Pharmacoepidemiol Drug Saf Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1099-1557
DOI:10.1002/pds.70304